Compare ZYME & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZYME | VERX |
|---|---|---|
| Founded | 2003 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2022 | 2020 |
| Metric | ZYME | VERX |
|---|---|---|
| Price | $27.00 | $11.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $38.90 | $28.29 |
| AVG Volume (30 Days) | 522.6K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $105,965,000.00 | ★ $748,444,000.00 |
| Revenue This Year | $180.13 | $12.78 |
| Revenue Next Year | N/A | $11.61 |
| P/E Ratio | ★ N/A | $302.25 |
| Revenue Growth | ★ 38.87 | 12.25 |
| 52 Week Low | $10.69 | $10.59 |
| 52 Week High | $28.49 | $42.44 |
| Indicator | ZYME | VERX |
|---|---|---|
| Relative Strength Index (RSI) | 63.62 | 38.03 |
| Support Level | $22.28 | N/A |
| Resistance Level | $27.35 | $20.04 |
| Average True Range (ATR) | 1.04 | 0.64 |
| MACD | 0.18 | 0.04 |
| Stochastic Oscillator | 91.56 | 41.54 |
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.